Literature DB >> 25932254

De novo malignancies in renal transplant recipients: experience at a single center in China.

Bin Wu1, Kai Wang1, Chun-Ba Mo1, Zhong-Yang Shen1.   

Abstract

OBJECTIVE: Post-transplant malignancies are a major cause of morbidity and mortality after renal transplantation. This retrospective study investigated the incidence and outcome of de novo malignancies following kidney transplantation in a single China kidney transplantation center.
MATERIALS AND METHODS: Between 1989 and 2010, 1467 patients underwent kidney transplantation at transplantation center of Tianjin First Central Hospital of Tianjin Medical University. Data were analyzed for tumor incidence, clinical characteristics, and outcome. A review of the literature is also summarized.
RESULTS: After 1,467 renal transplantations, 5 men and 9 women (sex ratio 5:9) with a mean age of 54 years (21-64) were included for malignancies, an overall incidence of 0.954%. Urinary tract malignancies represented the most frequent malignancies (57%). The time of postoperative tumor occurring varied from 1 to 133 months with an average value of 42.78 months. Among them, 4 died and the mortality rate was 28.6%.
CONCLUSIONS: In short, with the increasing of transplant patients and the prolonging of survival time with kidney, the occurrence of malignancies will be increasing. This requires that we should set up perfect transplant follow-up system, and do regular follow-up and careful physical examination, do not overlook any early feature of tumor, at last achieve early diagnosis of tumor, and early treatment to improve the cure rate of postoperative malignancies of renal transplantation.

Entities:  

Keywords:  Kidney transplantation; clinical characteristics; immunosuppression; incidence; neoplasms; outcome

Year:  2015        PMID: 25932254      PMCID: PMC4402901     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  10 in total

Review 1.  Malignancy after transplantation.

Authors:  Joseph F Buell; Thomas G Gross; E Steve Woodle
Journal:  Transplantation       Date:  2005-10-15       Impact factor: 4.939

2.  Cancer risk in patients on dialysis and after renal transplantation.

Authors:  S A Birkeland; H Løkkegaard; H H Storm
Journal:  Lancet       Date:  2000-05-27       Impact factor: 79.321

3.  Transitional cell carcinoma in renal transplant recipients.

Authors:  C-H Liao; S-C J Chueh; M-K Lai; J Chen
Journal:  Transplant Proc       Date:  2004-09       Impact factor: 1.066

4.  Minimizing the risk of posttransplant malignancy.

Authors:  Josep M Campistol
Journal:  Transplantation       Date:  2009-04-27       Impact factor: 4.939

Review 5.  Malignancy in kidney transplant recipients.

Authors:  Anil Kapoor
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 6.  Aristolochic acid nephropathy: a worldwide problem.

Authors:  Frédéric D Debelle; Jean-Louis Vanherweghem; Joëlle L Nortier
Journal:  Kidney Int       Date:  2008-04-16       Impact factor: 10.612

Review 7.  Cancers after renal transplantation.

Authors:  Germaine Wong; Jeremy R Chapman
Journal:  Transplant Rev (Orlando)       Date:  2008-04       Impact factor: 3.943

8.  Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients.

Authors:  A C Webster; J C Craig; J M Simpson; M P Jones; J R Chapman
Journal:  Am J Transplant       Date:  2007-07-19       Impact factor: 8.086

9.  Malignancies in 2,753 kidney recipients transplanted during a 39-year experience.

Authors:  L Berardinelli; P G Messa; E Pozzoli; C Beretta; G Montagnino
Journal:  Transplant Proc       Date:  2009-05       Impact factor: 1.066

10.  Spectrum of cancer risk among US solid organ transplant recipients.

Authors:  Eric A Engels; Ruth M Pfeiffer; Joseph F Fraumeni; Bertram L Kasiske; Ajay K Israni; Jon J Snyder; Robert A Wolfe; Nathan P Goodrich; A Rana Bayakly; Christina A Clarke; Glenn Copeland; Jack L Finch; Mary Lou Fleissner; Marc T Goodman; Amy Kahn; Lori Koch; Charles F Lynch; Margaret M Madeleine; Karen Pawlish; Chandrika Rao; Melanie A Williams; David Castenson; Michael Curry; Ruth Parsons; Gregory Fant; Monica Lin
Journal:  JAMA       Date:  2011-11-02       Impact factor: 157.335

  10 in total
  1 in total

Review 1.  Current Status of Malignant Tumors after Organ Transplantation.

Authors:  Bairu Shen; Zhuofei Cen; Minghua Tan; Changshan Song; Xuhui Wu; Jiaqing Wang; Minqian Huang
Journal:  Biomed Res Int       Date:  2022-02-18       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.